Intuitive Surgical, Inc. $ISRG Shares Purchased by Amalgamated Bank

Amalgamated Bank boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% in the second quarter, HoldingsChannel.com reports. The firm owned 81,542 shares of the medical equipment provider’s stock after acquiring an additional 1,772 shares during the period. Amalgamated Bank’s holdings in Intuitive Surgical were worth $44,311,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its holdings in Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after purchasing an additional 453,335 shares during the period. Invesco Ltd. boosted its holdings in shares of Intuitive Surgical by 1.7% during the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after acquiring an additional 71,794 shares during the period. Northern Trust Corp boosted its holdings in shares of Intuitive Surgical by 0.3% during the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after acquiring an additional 11,988 shares during the period. Wellington Management Group LLP boosted its holdings in shares of Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after acquiring an additional 457,080 shares during the period. Finally, Nuveen LLC acquired a new position in shares of Intuitive Surgical during the first quarter valued at $1,715,899,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 1.4%

Shares of Intuitive Surgical stock opened at $537.59 on Thursday. The company’s 50-day moving average price is $461.96 and its two-hundred day moving average price is $498.01. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The stock has a market cap of $192.72 billion, a PE ratio of 71.11, a price-to-earnings-growth ratio of 5.01 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the previous year, the business earned $1.84 earnings per share. Intuitive Surgical’s revenue for the quarter was up 22.9% compared to the same quarter last year. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on ISRG. Argus boosted their price target on shares of Intuitive Surgical from $600.00 to $630.00 in a report on Monday. Robert W. Baird set a $655.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. The Goldman Sachs Group upped their price objective on shares of Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CEO David J. Rosa sold 24,500 shares of the business’s stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at approximately $128,266,872.80. The trade was a 9.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Gary S. Guthart sold 2,800 shares of the business’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $546.27, for a total value of $1,529,556.00. Following the sale, the insider owned 17,120 shares in the company, valued at approximately $9,352,142.40. The trade was a 14.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 96,011 shares of company stock valued at $50,309,042 in the last quarter. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.